4.6 Review

Prognostic value of stem-like circulating tumor cells in patients with cancer: a systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors

Yaolu Wei et al.

Summary: This review discusses the relationship and pathway of ALDH1 with various solid tumors. It proposes that ALDH1 may serve as a diagnosis and therapeutic target for CSC, providing new insights and new strategies for reliable tumor treatment.

FRONTIERS IN ONCOLOGY (2022)

Review Medicine, Research & Experimental

EMT, cancer stem cells and autophagy; The three main axes of metastasis

Ghader Babaei et al.

Summary: Epithelial-mesenchymal transition (EMT) and Cancer stem-like cells (CSCs) are major factors contributing to cancer cell metastasis. Autophagy has recently gained attention, playing a dual role in cancer cell development depending on cancer type, tissue, and stage. Studies show different signaling pathways are involved in cancer stem cells, autophagy, and EMT. Investigating effective signaling pathways in all three processes could help determine appropriate therapeutic goals.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Medicine, General & Internal

Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma

Wen Zhang et al.

Summary: The study found that telomerase-positive circulating tumor cells can predict poor prognosis in patients with glioma, correlating with neutrophil activation. RNA sequencing results showed that postoperative CTCs were positively correlated with innate immune responses, but negatively correlated with cytotoxic response.

BMC MEDICINE (2021)

Article Oncology

ALDH1A1 Activity in Tumor-Initiating Cells Remodels Myeloid-Derived Suppressor Cells to Promote Breast Cancer Progression

Cuicui Liu et al.

Summary: The enzymatic activity of ALDH1A1 promotes breast tumor growth by decreasing intracellular pH and triggering NFkB signaling. Inhibitors of ALDH1A1 and activation of T-cell immunity can cooperatively inhibit tumor growth. ALDH1A1 induces MDSC expansion and creates a pro-cancer immune microenvironment in breast cancer, suggesting a new therapeutic target.

CANCER RESEARCH (2021)

Article Health Care Sciences & Services

Cancer Stem Cell-Like Circulating Tumor Cells Are Prognostic in Non-Small Cell Lung Cancer

Eva Obermayr et al.

Summary: This study highlighted the importance of molecular characterization of circulating tumor cells (CTCs) in NSCLC patients. The analysis found that cancer stem cell-related transcripts were significantly associated with overall survival at both primary diagnosis and disease progression.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Review Oncology

Metastasis-Initiating Cells and Ecosystems

Joan Massague et al.

Summary: Metastasis-initiating cells (MIC) are cancer cells with stem-like and immune-evasive properties that adopt regenerative progenitor phenotypes, enabling them to survive the stresses of metastasis and evade immune surveillance. Understanding the molecular mechanisms of MIC phenotypes and host tissue ecosystems is crucial for developing improved cancer therapeutics.

CANCER DISCOVERY (2021)

Article Oncology

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma

Yongrong Lei et al.

Summary: The study found a strong correlation between Nanog expression in CTCs and poor prognosis in HCC patients, suggesting that Nanog expression could be a valuable marker for tumor progression evaluation. The detection and analysis of CTC markers (EpCAM, CK8, 18, CD45, Vimentin, Twist, and 19) and CSCs markers (NANOG) are crucial in predicting HCC recurrence and prognosis.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Circulating tumor cells: biology and clinical significance

Danfeng Lin et al.

Summary: CTCs, tumor cells that have sloughed off the primary tumor and circulate in the blood, have potential for identifying targets against cancer metastasis. Detecting these rare CTCs in the massive pool of blood cells is challenging, but emerging detection technologies have deepened our understanding of their biology and clinical applications. Molecular markers, such as epithelial cell adhesion molecule, play a key role in CTC detection, with properties like epithelial-to-mesenchymal transition and stemness indicating increased metastatic capacity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Technologies for circulating tumor cell separation from whole blood

Petra Banko et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

The viable circulating tumor cells with cancer stem cells feature, where is the way out?

Y. T. Luo et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Oncology

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O'Flaherty et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2017)

Review Pathology

Cancer Stem Cells: Basic Concepts and Therapeutic Implications

Dany Nassar et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Review Multidisciplinary Sciences

Metastatic colonization by circulating tumour cells

Joan Massague et al.

NATURE (2016)

Article Oncology

Circulating Tumor Cells and Cancer Stem Cells: Clinical Implications in Nonmetastatic Breast Cancer

M. Sayed et al.

BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)

Article Biotechnology & Applied Microbiology

Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer

Man Li et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Review Oncology

OPINION Challenges in circulating tumour cell research

Catherine Alix-Panabieres et al.

NATURE REVIEWS CANCER (2014)

Review Biochemistry & Molecular Biology

The epigenetics of epithelial-mesenchymal plasticity in cancer

Wai Leong Tam et al.

NATURE MEDICINE (2013)

Review Cell Biology

Circulating tumor cells: approaches to isolation and characterization

Min Yu et al.

JOURNAL OF CELL BIOLOGY (2011)

Article Health Care Sciences & Services

GRADE guidelines: 7. Rating the quality of evidence-inconsistency

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Editorial Material Oncology

Circulating Tumor Cells: Not All Detected Cells Are Bad and Not All Bad Cells Are Detected

Max S. Wicha et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Review Multidisciplinary Sciences

A Perspective on Cancer Cell Metastasis

Christine L. Chaffer et al.

SCIENCE (2011)

Review Cell & Tissue Engineering

Concise Review: Emerging Concepts in Clinical Targeting of Cancer Stem Cells

Zeshaan A. Rasheed et al.

STEM CELLS (2011)

Review Oncology

Clinical relevance and biology of circulating tumor cells

Natalia Bednarz-Knoll et al.

BREAST CANCER RESEARCH (2011)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Cell Biology

Molecular markers in circulating tumour cells from metastatic colorectal cancer patients

Paola Gazzaniga et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Medicine, Research & Experimental

Practical methods for incorporating summary time-to-event data into meta-analysis

Jayne F. Tierney et al.

TRIALS (2007)

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)